Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
0.9400
-0.0322 (-3.31%)
At close: Oct 23, 2026, 4:00 PM EDT
0.9524
+0.0124 (1.32%)
After-hours: Oct 23, 2026, 7:55 PM EDT
Tvardi Therapeutics Employees
Tvardi Therapeutics had 12 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Tvardi Therapeutics the 40,003rd largest employer in the world and 5,979th in the United States.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,171,917
Market Cap
12.54M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 12 | 0 | - |
| Dec 31, 2024 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Karyopharm Therapeutics | 228 |
| Pluri | 113 |
| Cerenome | 28 |
| Daré Bioscience | 24 |
| BioCardia | 21 |
| Radiopharm Theranostics | 14 |
| Lipocine | 14 |
| Actuate Therapeutics | 12 |
TVRD News
- 3 days ago - Tvardi Therapeutics initiated with a Buy at Chardan - TheFly
- 9 days ago - Tvardi Therapeutics to Participate in Chardan's 10th Annual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Tvardi announces publication of preclinical data on STAT3 inhibitor - TheFly
- 4 weeks ago - New Preclinical Data Further Support Potential for Tvardi's STAT3 Inhibitors in Ulcerative Colitis (UC) - GlobeNewsWire
- 6 weeks ago - Tvardi Therapeutics assumed with a Buy at Lucid Capital - TheFly
- 1 month ago - Tvardi Therapeutics to Participate in Upcoming Investor Events - GlobeNewsWire
- 2 months ago - Tvardi Therapeutics reports Q2 EPS (69c), consensus (63c) - TheFly
- 2 months ago - Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update - GlobeNewsWire